Partnership reinforces continued investment in digitization, automation, and client-facing transparency

Charles River Laboratories International, Inc. (NYSE:CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new capability within Charles River's Apollo® platform that connects and digitizes laboratory execution, built on Autolomous's autoloMATE® digital Laboratory Execution System (LES). The launch demonstrates continued progress onCharles River's strategic commitment to modernize and digitize laboratory workflows. Apollo® Orchestrate™ marks a significant milestone in the Company’s broader, ongoing transition toward a fully digital laboratory experience which is connected, compliant, and scalable.

The deployment brings Apollo Orchestrate's digital execution and workflow-automation capabilities, powered by Autolomous’s autoloMATE, to Charles River Biologics Testing Solutions sites across North America and Europe, supporting quality control (QC) testing within the Good Manufacturing Practice (GMP) setting. Apollo Orchestrate connects Charles River's laboratory systems, including Apollo and LabWare LIMS, supporting digital traceability from sample submission through execution to release.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.